Fahmida Hai

Fahmida Hai

Auto-generated profile, based on publicly available information

Fahmida Hai

Tekurai Inc., 2000 NW Military Hwy #10, San Antonio, Texas 78213, United States

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 August 2025
Verified
Book Chapter
Open access
Don RoosanDon Roosan
Don Roosan
RKRubayat Islam Khan
Rubayat Islam Khan
TKTiffany Khou
Tiffany Khou
SNSaif Nirzhor
Saif Nirzhor
FHFahmida Hai
Fahmida Hai
BPBrian Provencher
Brian Provencher
The objective of this paper is to investigate the structural stability, dynamic properties, and potential interactions among Amyloid Precursor Protein (APP), Tau, and Alpha-synuclein through a series of molecular dynamics simulations that integrate publicly available structural data, detailed force-field parameters, and comprehensive analytical protocols. By focusing on these three proteins, which are each implicated in various neurodegenerative disorders, the study aims to elucidate how their conformational changes and interprotein contact sites may influence larger biological processes. Through rigorous evaluation of their folding behaviors, energetic interactions, and residue-specific functions, this work contributes to the broader understanding of protein aggregation mechanisms and offers insights that may ultimately guide therapeutic intervention strategies.

29 April 2025 in Blockchain in Healthcare Today
Verified
Journal Article
Open access
PDF file
Don RoosanDon Roosan
Don Roosan
RKRubayat Islam Khan
Rubayat Islam Khan
SNSaif Nirzhor
Saif Nirzhor
FHFahmida Hai
Fahmida Hai
ContextThe study proposes and evaluates a novel cybersecurity architecture for telehealth, resilient against future quantum computing cyber threats. By integrating Post-Quantum Cryptography (PQC) with Quantum Key Distribution (QKD) and privacy-preserving mechanisms, data confidentiality and immutability for patient records in a post-quantum era are ensured. MethodsA multi-layered design approach was adopted. PQC algorithms (e.g., CRYSTALS-Dilithium) were integrated at the blockchain consensus layer to resist quantum attacks. A Directed Acyclic Graph (DAG)-based ledger managed high transaction throughput and latency constraints typical of telehealth. A QKD-enhanced key management protocol leveraged quantum channels for secure exchanges. Zero-knowledge proofs (ZKPs) and secure multiparty computation (MPC) verified transactions without exposing sensitive patient data. A granular access control model used attribute-based encryption (ABE) and smart contracts to govern which participants could view or modify encrypted medical records. ResultsThe prototype was developed within a simulated telehealth network comprising hospitals, clinics, and patient devices. PQC signatures at the consensus layer provided effective resistance to both classical and anticipated quantum attacks. QKD facilitated secure key distribution, while ZKPs and MPC enabled validation of healthcare transactions without compromising patient privacy. Despite increased computational overhead, the DAG approach efficiently handled parallel transactions, indicating improved scalability compared to traditional linear blockchains. ConclusionA QKD-enhanced, PQC-driven framework successfully addresses critical security and privacy requirements, safeguarding medical data from emerging quantum threats. Although overhead and infrastructural costs are significant, sustained cryptographic resilience and robust patient confidentiality underscore its suitability for next-generation healthcare systems. Future studies should explore additional optimizations, homomorphic encryption, and larger-scale pilots under regulatory standards.

26 August 2025
Verified
Book Chapter
Open access
Don RoosanDon Roosan
Don Roosan
TKTiffany Khou
Tiffany Khou
SNSaif Nirzhor
Saif Nirzhor
RKRubayat Islam Khan
Rubayat Islam Khan
FHFahmida Hai
Fahmida Hai
ABAndrius Baskys
Andrius Baskys
Drug development for neurological conditions faces high costs, long timelines, and frequent failures. Drug repurposing offers a solution, enhanced by advanced computational methods. Using the Broad Institute’s Drug Repurposing Hub data, we applied Quantum Neural Networks (QNNs) and Liquid Neural Networks (LNNs) to predict repurposing opportunities. Focusing on drugs’ mechanisms, clinical phases, and targets, we adapted data for quantum hardware using IBM’s Qiskit. QNNs achieved strong results (accuracy = 0.85, F1-score = 0.81, AUC-ROC = 0.88), though LNNs performed better (accuracy = 0.89, F1-score = 0.86, AUC-ROC = 0.91). Despite quantum hardware limits, QNNs show promise for drug repurposing, with potential to surpass classical models as technology advances. This study underscores the value of QNNs and LNNs in accelerating neurological drug discovery through hybrid quantum-classical approaches.

29 June 2025 in arXiv
Verified
Preprint
Open access
PDF file
Don RoosanDon Roosan
Don Roosan
RKRubayat Khan
Rubayat Khan
SNSaif Nirzhor
Saif Nirzhor
TKTiffany Khou
Tiffany Khou
FHFahmida Hai
Fahmida Hai
The rapid expansion of biomolecular datasets presents significant challenges for computational biology. Quantum computing emerges as a promising solution to address these complexities. This study introduces a novel quantum framework for analyzing TART-T and TART-C gene data by integrating genomic and structural information. Leveraging a Quantum Neural Network (QNN), we classify hotspot mutations, utilizing quantum superposition to uncover intricate relationships within the data. Additionally, a Variational Quantum Eigensolver (VQE) is employed to estimate molecular ground-state energies through a hybrid classical-quantum approach, overcoming the limitations of traditional computational methods. Implemented using IBM Qiskit, our framework demonstrates high accuracy in both mutation classification and energy estimation on current Noisy Intermediate-Scale Quantum (NISQ) devices. These results underscore the potential of quantum computing to advance the understanding of gene function and protein structure. Furthermore, this research serves as a foundational blueprint for extending quantum computational methods to other genes and biological systems, highlighting their synergy with classical approaches and paving the way for breakthroughs in drug discovery and personalized medicine.

1 July 2025 in arXiv
Verified
Preprint
Open access
PDF file
Don RoosanDon Roosan
Don Roosan
SNSaif Nirzhor
Saif Nirzhor
RKRubayat Islam Khan
Rubayat Islam Khan
FHFahmida Hai
Fahmida Hai
MHMohammad Rifat Haider
Mohammad Rifat Haider
HIV epidemiological data is increasingly complex, requiring advanced computation for accurate cluster detection and forecasting. We employed quantum-accelerated machine learning to analyze HIV prevalence at the ZIP-code level using AIDSVu and synthetic SDoH data for 2022. Our approach compared classical clustering (DBSCAN, HDBSCAN) with a quantum approximate optimization algorithm (QAOA), developed a hybrid quantum-classical neural network for HIV prevalence forecasting, and used quantum Bayesian networks to explore causal links between SDoH factors and HIV incidence. The QAOA-based method achieved 92% accuracy in cluster detection within 1.6 seconds, outperforming classical algorithms. Meanwhile, the hybrid quantum-classical neural network predicted HIV prevalence with 94% accuracy, surpassing a purely classical counterpart. Quantum Bayesian analysis identified housing instability as a key driver of HIV cluster emergence and expansion, with stigma exerting a geographically variable influence. These quantum-enhanced methods deliver greater precision and efficiency in HIV surveillance while illuminating critical causal pathways. This work can guide targeted interventions, optimize resource allocation for PrEP, and address structural inequities fueling HIV transmission.

23 June 2025 in arXiv
Verified
Preprint
Open access
PDF file
Don RoosanDon Roosan
Don Roosan
SNSaif Nirzhor
Saif Nirzhor
RKRubayat Islam Khan
Rubayat Islam Khan
FHFahmida Hai
Fahmida Hai
This paper presents a novel quantum-enhanced prototype for drug repurposing and addresses the challenge of managing massive genomics data in precision medicine.